Home > News
Read real stories from people affected by MND, get inspired by the incredible ways people are supporting our cause and hear more about the latest advancements in research, care and support.
Phase 3 clinical trial of tauroursodeoxycholic acid (TUDCA) fails to meet primary aim of reducing the progression of MND.